← Back to Analyst Consensus 
SPRB Buy
SPRUCE BIOSCIENCES, INC.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 24, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Sep 17, 2026 | Lake Street | initiate | — → Buy | — | 47% |
| Aug 17, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 13, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jul 13, 2026 | B. Riley Securities | initiate | — → Buy | — | 55% |
| Jun 16, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Jun 9, 2026 | Jones Trading | initiate | — → Buy | — | 50% |
| Jun 1, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 14, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Apr 27, 2026 | Craig-Hallum | initiate | — → Buy | — | 54% |
| Mar 10, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Mar 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 19, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $200 | 44% |
| Dec 23, 2025 | Oppenheimer | initiate | — → Outperform | $283 | 52% |
| Dec 3, 2025 | Leerink Partners | upgrade | Market Perform → Outperform | $160 | 51% |
| Nov 11, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $259 | 47% |
| Oct 28, 2025 | JMP Securities | upgrade | Market Perform → Market Outperform | $254 | 53% |
| Oct 21, 2025 | Leerink Partners | maintain | Market Perform → Market Perform | $160 | 51% |
| Apr 16, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $0.5 | 55% |
| Dec 16, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $0 | 44% |
| Dec 12, 2024 | Guggenheim | reiterate | Neutral → Neutral | $0 | 52% |
| Dec 11, 2024 | JMP Securities | downgrade | Market Outperform → Market Perform | $3 | 53% |
| Dec 11, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $1.5 | 55% |
| Dec 11, 2024 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Nov 12, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $2 | 55% |
| Aug 19, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Aug 13, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $2 | 55% |
| Jun 13, 2024 | Oppenheimer | maintain | Outperform → Outperform | $3 | 52% |
| Jun 5, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Mar 14, 2024 | RBC Capital | downgrade | Outperform → Sector Perform | $2 | 55% |
| Mar 14, 2024 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Mar 14, 2024 | Leerink Partners | downgrade | Outperform → Market Perform | $2 | 51% |
| Mar 14, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $3 | 53% |
| Mar 14, 2024 | Ladenburg Thalmann | downgrade | Buy → Neutral | $0 | 45% |
| Mar 14, 2024 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Mar 5, 2024 | RBC Capital | reiterate | Outperform → Outperform | $9 | 55% |
| Feb 26, 2024 | RBC Capital | maintain | Outperform → Outperform | $9 | 55% |
| Feb 21, 2024 | Guggenheim | initiate | — → Buy | $10 | 52% |
| Nov 20, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 13, 2023 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| Sep 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 8, 2023 | SVB Leerink | upgrade | Market Perform → Outperform | $9 | — |
| Aug 18, 2023 | Oppenheimer | maintain | Outperform → Outperform | $7 | 52% |
| Aug 18, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 16, 2023 | JMP Securities | maintain | Outperform → Outperform | $8 | 53% |
| Aug 15, 2023 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
| Jun 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 23, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $8 | 52% |
| May 16, 2023 | RBC Capital | reiterate | Outperform → Outperform | $8 | 55% |
Price Target Trend
Jun 23, 2026 Latest: $148 Oct 22, 2026
EPS Estimates
0y $-25.32
Lo: $-32.69 Hi: $-16.26
8 analysts ▲1
+1q $-5.10
Lo: $-6.91 Hi: $-1.62
8 analysts 0q $-5.51
Lo: $-6.92 Hi: $-4.24
8 analysts +1y $4.97
Lo: $-19.26 Hi: $38.23
8 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days